Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E Asano is active.

Publication


Featured researches published by E Asano.


Value in Health | 2015

Use of A Multi-Decision Criteria Analysis to Support Healthcare Decision-Making for Private Payers in Brazil: Development of a Model To Guide Reimbursement Decisions.

Nascimento do; E Asano

A value measurement Multi Decision Criteria Analysis (MCDA) model was developed in order to reflect different dimensions that influence healthcare decisions. A literature review was performed in order to identify the most common criteria and scores scales to be included in the model, which was further complemented by expert opinion. Analytical hierarchy process was used to weight the importance of each dimension by pairwise comparisons. A group representing different stakeholders (academia, payer, industry and physician) was formed in order to consider different perspectives when validating the final model.


Value in Health | 2017

Treatment Sequencing for Patients With Multiple Myeloma with at Least One Prior Line: Comparing Progression-Free Survival and Costs Under a Private Payer Perspective

E Asano; A Maiolino; E Martins


Value in Health | 2016

Budget Impact Analysis Of The Introduction Of Darunavir 800 Mg Qd For The 2nd Line Treatment Of Hiv-Infected Treatment-Experienced Adults On The Brazilian National Hiv Program

Ka Ferreira; Ja Neves; E Asano; La Magno; Rg Loureiro


Value in Health | 2016

COST-MINIMIZATION ANALYSIS OF TNF INHIBITORS IN THE TREATMENT OF SPONDYLOARTHRITIS (PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS) UNDER THE BRAZILIAN PUBLIC HEALTH SYSTEM PERSPECTIVE

L. Scaccabarozzi; E Asano; A.C. Monteiro


Value in Health | 2016

COST-MINIMIZATION ANALYSES OF BIOLOGICAL THERAPIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS UNDER THE BRAZILIAN PUBLIC HEALTH SYSTEM PERSPECTIVE

L. Scaccabarozzi; E Asano; A.C. Monteiro


Value in Health | 2016

Incidence Rates Of Patients Starting Treatment For Chronic Lymphocytic Leukemia In The Brazilian Public Health Care System: A Retrospective Epidemiologic Study Based On Datasus

H Paiva; E Asano


Value in Health | 2016

Budget Impact Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Cancer Patients Under the Brazilian Private Health Care System Perspective

L. Pititto; E Asano


Value in Health | 2016

BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR NAÏVE PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

L. Scaccabarozzi; E Asano; T.B. Guimarães


Value in Health | 2016

Budget Impact Analysis of the Incorporation of Ibrutinib for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia in the Brazilian Private Health Care System

H Paiva; E Asano


Value in Health | 2016

COST-MINIMIZATION ANALYSIS OF BIOLOGICAL DRUGS IN THE TREATMENT OF SPONDYLOARTHRITIS (PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS) UNDER THE BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE

L. Scaccabarozzi; E Asano; A.C. Monteiro

Collaboration


Dive into the E Asano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H Paiva

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors

Avatar

E Martins

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors

Avatar

Ja Neves

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

La Magno

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge